Immunome, Inc. (NASDAQ:IMNM) is one of the stocks Jim Cramer offered insights on. When a caller inquired about the stock, Cramer stated: “This company’s losing so much money, I know, but it’s Dr. Siegall… So therefore, if you want to speculate on it, fine. But we do not think that you’re investing.” Pixabay/Public Domain Immunome, Inc. (NASDAQ:IMNM) is a clinical-stage biotech company that focuses on developing targeted cancer treatments, with a leading drug candidate in late-stage testing and another ...